ABSTRACT
INTRODUCTION
Currently, there are several natural products and their analogs with antimitotic activity under development for the treatment of neoplastic diseases (11, (13) (14) (15) . Colchicine, derived from the plant Colchicum autumnale , was the first antimitotic agent to be characterized. Isolated in the 19th century, it was instrumental in the isolation and characterization of microtubules (11) . Microtubules are dynamic, labile, polar polymers composed primarily of tubulin heterodimers consisting of one α -and one β -tubulin subunit noncovalently linked (3, 9, 21) . Microtubules are a major intracellular component of cells involved in cell shape, cellular movement and division (3, 9, 12) . During cell division, microtubules form the mitotic spindle that lines up and properly separates the chromosomes to each new "daughter" cell (26) . Compounds such as colchicine interfere with the ability of cells to properly form the mitotic spindle causing the cells to arrest at metaphase. Cells arrested at metaphase with colchicine eventually die by the process of apoptosis (2, 4) .
The exact mechanism of colchicine on microtubule dynamics is unclear; however, it is known to first bind to a specific site on the β -tubulin subunit of the tubulin heterodimer. The tubulincolchicine complexes then become incorporated into the microtubule ends, leading to changes in the rate and extent of growing and shortening of microtubules (14, 15, 21, 27) . Tubulinbinding assays have been a useful screening tool to identify several new classes of structurally unrelated antimitotic compounds that can interact with tubulin at the colchicine-binding domain. Antimitotic compounds, such as combretastatin A4 and E7010, which bind to tubulin at the colchicine-binding domain, are either under development or in clinical trials as antineoplastic agents (7, 28) .
Several colchicine-binding assays, such as the DEAE-cellulose filter paper, gel filtration or activated charcoal assays, require the separation of bound colchicine from unbound colchicine (5, 8, 18, 24) . However, there are disadvantages to using separation techniques, for example, the introduction of extra steps for separating and washing, plus the potential decay of the complex. A previously developed fluorometric assay does not require the separation of the tubulin-colchicine complex with free colchicine. However, it is not as sensitive as [ 3 H]colchicine assays (1) . To overcome the disadvantages inherent with separation assays, we developed a novel [ 3 H]colchicine competition-binding scintillation proximity assay (SPA) using yttrium beads to evaluate antimitotic compounds in vitro. SPA technology overcomes the disadvantage of traditional filtration techniques because there are no separation steps and the reaction and counting are done in the same well.
This paper describes our novel 96-well [ 3 H]colchicine SPA using biotinlabeled tubulin and streptavidin-yttrium beads. The assay can be used to identi -fy novel compounds with potential antimitotic properties that compete with colchicine for the colchicine-binding site on tubulin.
Biotin-labeled tubulin is incubated first with unlabeled compound and radiolabeled ligand (Figure 1 ). Streptavidin-labeled SPA beads are added, and the radiolabel associated with tubulin is directly counted with no separation step. Our SPA bead method is a powerful tool-it overcomes the disadvantage of traditional filtration techniques because there are no separation steps. It is extremely easy to set up, multiple samples can be assayed and supply and labor costs are reduced as a result of the minimal volume and test reagents used.
MATERIALS AND METHODS

Chemicals
Special long-chain, biotin-labeled tubulin was purchased from Cytoskeleton (Denver, CO, USA). BioTechniques 157 
RESULTS AND DISCUSSION
Bead Concentration
The optimal bead concentration to obtain the maximum specific signal with low nonspecific background (NSB) was determined by adding varying amounts of yttrium beads to a fixed amount of [ 3 H]colchicine and tubulin. As Figure 2 shows, the specific signal increased linearly and became saturated above 0.08 mg/well. The NSB increased linearly from 0.01 to 0.16 mg/well. We chose 0.08 mg/well as our optimal bead concentration because it gave us a high specific signal while still having a low NSB (5%). Given the low NSB, our assay is suitable for high-throughput screening. Assays having a specific binding component of greater than 80% are suitable for high-volume screening because they are reproducible and reliable as drug discovery tools (25) .
Incubation Time
We examined the binding characteristics of colchicine to tubulin over time at 37°C. Colchicine was shown previously to reversibly bind to tubulin in a two-step manner involving a fast initial binding phase of relatively low affinity followed by a slow conformational change of the complex (10, 17, 20) . As previously described, we observed that colchicine binding to tubulin was biphasic using our SPA system. Our data corroborates the results of Luyckx et al. (20) in that there was a relatively quick phase in which approximately 60% of the binding occurred, followed by a slower phase (Figure 3) .
Effect of Solvents
Two solvents commonly used to dissolve drugs (DMSO and ethanol) were tested for their effect on the SPA counts. It was determined that the specific signal decreased as the concentration of ethanol or DMSO concentration was increased above 1% (Figure 4) . 
Determination of Colchicine Dissociation Constant of Binding (K d ) to Tubulin
The K d for colchicine binding to tubulin was determined by increasing the concentration of radioligand (0.005 -2.6 µ M) with a constant amount of tubulin (0.5 µ g). GraphPad Prism was used to determine the B max (total receptor number) and K d using nonlinear regression to fit the data to a one-site binding curve using the formula receptors expressed in the same units as specific binding and K d is the equilibrium dissociation constant (expressed in the same units as [L] ). The binding of colchicine to tubulin was saturable ( Figure 5 ). The K d for colchicine under our experimental conditions was 1.4 µ M, which was consistent with previously reported values (16, 20) . NSB increased in a linear manner as the concentration of radioligand was increased, and background accounted for only 3%-10% of the total counts. The portion of the curve to the right showing binding at higher radioligand concentrations did not reach complete saturation. We did not go higher because of the expense of the radioligand and the NSB might be too high a fraction of total binding.
Inhibition of Colchicine Binding to Tubulin
Validation of the assay was performed by competitively inhibiting [ 3 H]colchicine binding to tubulin with known microtubule inhibitors and comparing their K i values when possible. The competition assays were performed by holding the protein and radioligand concentrations constant and varying the concentration of the unlabeled competitor. The K i values for each compound were used to compare their effect on colchicine binding since IC 50 values tend to vary between laboratories because of the different methodologies used and variation in radioligand concentration. K i values were calculated using the Cheng-Prussof equation (6) . Nonlinear regression analysis was used to fit the data to a onesite competition-binding curve using GraphPad Prism. The K i values for combretastatin A4, E7010, podophyllotoxin, mebendazole, colcemid and colchicine, reported to bind to tubulin at the colchicine site range between 0.2-4.6 µ M, are listed in Table 1 . Taxol and vinblastine, which bind to different sites on tubulin, did not compete with [ 3 H]colchicine binding to tubulin at concentrations below 100 µ M. The values of various microtubule inhibitors in our SPA assay were consistent with K i values reported by others (Table 1) .
In summary, our assay is useful for evaluating antimitotic compounds in vitro and can overcome the disadvantage of traditional filtration techniques since there are no separation steps. Our SPA bead method is extremely easy to set up, multiple samples can be assayed, supply and labor costs are minimal and it has utility as a high-throughput screening tool.
